Valuation: INVO Fertility, Inc.

Market Cap 2.8M 2.5M 2.3M 2.09M 3.96M 263M 4.06M 27.54M 10.98M 141M 10.52M 10.3M 443M P/E 2026 *
-0.03x
P/E 2027 * -
Enterprise Value 2.8M 2.5M 2.3M 2.09M 3.96M 263M 4.06M 27.54M 10.98M 141M 10.52M 10.3M 443M EV / Sales 2026 *
0.27x
EV / Sales 2027 * 0.17x
Free-Float
99.52%
Yield 2026 *
-
Yield 2027 * -
1 day+9.81%
1 week+28.42%
Current month+23.04%
1 month-19.24%
3 months-44.58%
6 months-65.84%
Current year-84.39%
1 week 1.87
Extreme 1.87
2.39
1 month 1.59
Extreme 1.59
3.07
Current year 1.59
Extreme 1.59
91.6
1 year 1.59
Extreme 1.59
98
3 years 1.59
Extreme 1.59
7,141.83
5 years 1.59
Extreme 1.59
7,141.83
10 years 1.59
Extreme 1.59
7,141.83
Date Insider Type Main position Quantity % Market Cap. Importance
12/30/25 Other

Chief Financial Officer

4,399 0.2326%
12/3/25 Sell

Director

7 0.0004%
8/26/25 Other

Director

45,000 4.8477%
Change 5-day change 1-year change 3-year change Capi.($)
+9.81%+28.42%-97.27% - 2.55M
+0.53%+0.32%-12.54%+18.13% 190B
+0.97%+3.53%+11.49%+46.65% 125B
-0.04%+6.17%-8.51%+20.27% 124B
-1.65%+1.98%-38.20%+8.64% 99.31B
+3.66%+2.34%-4.14%+75.67% 63.65B
+1.59%+8.38%+21.04%-7.32% 57.71B
+4.53%+5.21%-0.25%+68.75% 53.26B
+1.70%-3.36%-5.62%+54.11% 47.03B
-0.13%+1.32%+3.73%-7.69% 36.15B
Average +2.10%+4.40%-13.03%+30.80% 80B
Weighted average by Cap. +0.88%+2.17%-6.28%+28.84%

Financials

2026 *2027 *
Net sales 10.42M 9.3M 8.56M 7.77M 14.72M 977M 15.08M 102M 40.8M 523M 39.11M 38.27M 1.65B 16.46M 14.69M 13.52M 12.27M 23.25M 1.54B 23.83M 162M 64.46M 826M 61.78M 60.46M 2.6B
Net income -5.44M -4.86M -4.47M -4.06M -7.69M -510M -7.88M -53.48M -21.32M -273M -20.43M -19.99M -860M -3.03M -2.7M -2.49M -2.26M -4.27M -284M -4.38M -29.73M -11.85M -152M -11.36M -11.11M -478M
Net Debt - -
Projected Income Statement - Annual - INVO Fertility, Inc.
Logo INVO Fertility, Inc.
INVO Fertility Inc. is a healthcare services fertility company, which is engaged in expanding access to assisted reproductive technology (ART) care to patients in need. The Company’s principal commercial strategy is focused on building, acquiring, and operating fertility clinics, including INVO Centers dedicated primarily to offering the intravaginal culture (IVC) procedure enabled by its INVOcell medical device (INVOcell) and United States-based, profitable in vitro fertilization (IVF) clinics. The Company has four operational fertility clinics in the United States. The Company is also engaged in the sale and distribution of INVOcell to third-party owned and operated fertility clinics. INVOcell is a proprietary medical device that allows fertilization and early embryo development to take place in vivo within the woman's body. The IVC procedure provides patients with a more connected, intimate, and affordable experience in comparison to other ART treatments.
Employees
-
Date Price Change Volume
26-11-09 US$2.350 +9.81% 22,139
26-11-06 US$2.140 +5.42% 37,016
26-11-05 US$2.030 -0.98% 49,032
26-11-04 US$2.050 +5.67% 40,872
26-11-03 US$1.940 +6.01% 18,822
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
2.350USD
Average target price
80.00USD
Spread / Average Target
+3,304.26%